XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Contingent liabilities are re-measured to fair value each reporting period using projected financial targets, discount rates, probabilities of payment, and projected payment dates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model. Projected financial targets are based on our most recent internal operational budgets and may take into consideration alternate scenarios that could result in more or less profitability for the respective service line. Increases or decreases in projected financial targets and probabilities of payment may result in significant changes in the fair value measurements. Increases in discount rates and the time to payment may result in lower fair value measurements. Increases or decreases in any of those inputs in isolation may result in a significantly lower or higher fair value measurement.
The Company’s fair value measurements are classified and disclosed in one of the following three categories:
•Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
•Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;
•Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
The table below presents activity within Level 3 of the fair value hierarchy, our liabilities carried at fair value relating to the medac settlement, for the three months ended March 31, 2025:
Level 3
(In thousands)Contingent
liabilities
Balance at January 1, 2025$974 
Liability fair value adjustment99 
Total change in foreign exchange40 
Balance at March 31, 2025$1,113 
The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value as of March 31, 2025 and December 31, 2024 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value.
March 31, 2025
(In thousands)Quoted Prices in
Active Markets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Assets:
Money market funds$11 $— $— $11 
U.S. government agency bonds— 46,120 — 46,120 
Total Assets$11 $46,120 $— $46,131 
Liabilities:
Contingent Liability$— $— $1,113 $1,113 
Total Liabilities$— $— $1,113 $1,113 

December 31, 2024
(In thousands)Quoted Prices in
Active Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)		Total
Assets:
Money market funds$9 $— $— $9 
U.S. government agency bonds— 20,821 — 20,821 
Total Assets$9 $20,821 $— $20,830 
Liabilities:
Contingent Liability$— $— $974 $974 
Total Liabilities$— $— $974 $974